Ordinary Adjustment | Enhanced Consciousness Index | Effective Date 2nd March 2023
In the ordinary rebalance, the following index composition will be implemented effective open 03.02.2023:
| JOHNSON & JOHNSON |
| Biogen Inc. |
| UCB S.A. |
| Sarepta Therapeutics, Inc. |
| Neurocrine Biosciences, Inc. |
| Jazz Pharmaceuticals Public Limited Company |
| Karuna Therapeutics, Inc. |
| Cerevel Therapeutics Holdings Inc |
| INTRA-CELLULAR THERAPIES INC |
| Alkermes Plc |
| Denali Therapeutics Inc. |
| H. Lundbeck A/S Class B |
| PTC Therapeutics, Inc. |
| ACADIA Pharmaceuticals Inc. |
| SAGE THERAPEUTICS INC |
| MYRIAD GENETICS INC |
| GH RESEARCH PLC |
| COMPASS PATHWAYS PLC |
| ATAI LIFE SCIENCES B.V |
| MIND MEDICINE MINDMED INC |
| RELMADA THERAPEUTICS INC. |
| SEELOS THERAPEUTICS INC |
| NRX PHARMACEUTICALS INC |
| TONIX PHARMACEUTICALS HOLDIN |
| VISTAGEN THERAPEUTICS INC |